Source: Annual Congress 2013 –Drug-resistant tuberculosis: new clinical and public health insights
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
H. R. Stagg, T. Cohen, M. C. Becerra, L. F. Anderson, I. Abubakar (London, United Kingdom; Boston, United States Of America). A tale of two settings: The role of the Beijing genotype in the rise of multidrug resistant tuberculosis. Eur Respir J 2013; 42: Suppl. 57, 193

Member's Comments

No comment yet.

Related content which might interest you: A tale of two settings: the role of the Beijing genotype in the epidemiology of multidrug-resistant tuberculosis Source: Eur Respir J 2014; 43: 632-635 Year: 2013 Prevalence of aminoglycoside resistance among different MDR tuberculosis cases in Ukraine Source: Annual Congress 2013 –Drug-resistant tuberculosis Year: 2013 Genotypes and drug resistance patterns of multi-drug-resistant mycobacterium tuberculosis strains in Pakistan Source: International Congress 2015 – Non-tuberculous mycobacteria and molecular microbiology Year: 2015 Frequency of risk factors for multi-drug resistant tuberculosis among the patients enrolled at multi-drug resistant clinic in a tertiary care hospital, Pakistan Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 1 Year: 2014 Multidrug resistant tuberculosis (MDR – TB) treatment outcomes in Iran Source: Eur Respir J 2004; 24: Suppl. 48, 657s Year: 2004 Alarming levels of drug-resistant tuberculosis in Belarus: results of a survey in Minsk Source: Eur Respir J 2012; 39: 1425-1431 Year: 2012 Drug resistant tuberculosis in Odessa, Southern Ukraine: Beijing family strains prevalence and the role of prisons in drug resistant TB transmission Source: Eur Respir J 2006; 28: Suppl. 50, 290s Year: 2006 Spread of tuberculosis among household contacts of multi drug resistant tuberculosis (MDRTB) patients Source: International Congress 2014 – Tuberculosis: epidemiology and public health Year: 2014 Treatment outcome of multi-drug resistant tuberculosis in Varanasi, India Source: Eur Respir J 2002; 20: Suppl. 38, 615s Year: 2002 Estimating costs for treating patients with multi-drug resistant tuberculosis (MDR TB) under the regional tuberculosis control program, Tomsk (Russia) Source: International Congress 2015 – Treatment of TB (MDR-TB): co-morbidities, adverse effects and outcomes Year: 2015 Genetic diversity of multidrug resistant mycobacterium tuberculosis strains isolated from tuberculosis patients in Iran, using MIRU-VNTR technique Source: International Congress 2016 – Microbiology: bronchoalveolar lavage (BAL) and PCR Year: 2016 A multicentric cohort analysis of culture conversion and reversion in multidrug resistant tuberculosis (MDRTB) patients Source: Annual Congress 2013 –Drug-resistant tuberculosis: new clinical and public health insights Year: 2013 Prevalence of fluoroquinolon-resistance among different MDR tuberculosis cases in Ukraine Source: Annual Congress 2013 –Drug-resistant tuberculosis Year: 2013 Tuberculosis in Estonia: a major impact of Russian MDR Mycobacterium tuberculosis Beijing B0/W148-cluster Source: Virtual Congress 2020 – Multidrug-resistant tuberculosis Year: 2020 Molecular surveillance of multi-drug resistant tuberculosis in Europe Source: Annual Congress 2007 - Multidrug-resistant tuberculosis and the emerging threat of extensively drug-resistant tuberculosis Year: 2007 The global risk of dying from multidrug-resistant tuberculosis (MDR-TB) Source: International Congress 2014 – Tuberculosis epidemiology: novel features Year: 2014 Genetic markers of multi-drug and extensive drug resistant M. tuberculosis in Kyrgyz Republic Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: diagnostic tools Year: 2012 Frequency of multi-drug resistant M.tuberculosis and HLA-class-2 gene associations in tuberculosis patients in the Republic of Tuva Source: Annual Congress 2008 - Clinical epidemiology of tuberculosis I Year: 2008 High incidence of the Beijing strains among multi drug resistance isolates of Mycobacterium tuberculosis from extra pulmonary tuberculosis cases in northern India Source: Annual Congress 2012 - Non-tuberculous and tuberculous mycobacterial infections: from epidemiology to clinical findings Year: 2012 Effectiveness of the WHO regimen for treatment of multidrug resistant tuberculosis (MDR-TB) Source: Annual Congress 2013 –Drug-resistant tuberculosis: new clinical and public health insights Year: 2013